ATI RN
ATI Pharmacology Proctored Exam 2019 Questions
Question 1 of 5
A healthcare professional is caring for a client who is receiving treatment with carboplatin. Which of the following findings should the healthcare professional monitor?
Correct Answer: B
Rationale: The healthcare professional should monitor the client for ototoxicity when receiving carboplatin. Ototoxicity is a known serious adverse effect associated with this medication, characterized by damage to the inner ear structures leading to hearing loss or balance issues. Monitoring for hearing changes and balance problems is crucial to detect ototoxicity early and prevent further complications.
Question 2 of 5
A client is prescribed Clopidogrel. Which of the following laboratory values should the nurse monitor to assess for potential adverse effects?
Correct Answer: B
Rationale: Clopidogrel is an antiplatelet medication that works by inhibiting platelet aggregation. Therefore, the nurse should monitor the client's platelet count to assess for potential bleeding complications. Changes in platelet count can indicate the effectiveness of Clopidogrel therapy and help prevent adverse effects related to clotting or bleeding.
Question 3 of 5
A client has a new prescription for a Nitroglycerin transdermal patch. Which of the following instructions should the nurse include?
Correct Answer: D
Rationale: The correct instruction is to apply the Nitroglycerin transdermal patch to a hairless area of skin. This is important for proper absorption of the medication. Additionally, rotating the patch to different sites each day helps prevent skin irritation and ensures optimal therapeutic effect. Applying the patch to the same site each day can lead to skin irritation or tolerance development. Removing the patch at night is not necessary as the patch is typically worn continuously to provide a consistent level of medication. Covering the patch with a heating pad is contraindicated as it can increase drug absorption, potentially leading to adverse effects.
Question 4 of 5
A client is prescribed Diltiazem. Which of the following findings should the nurse monitor?
Correct Answer: B
Rationale: In the case of a client prescribed Diltiazem, the nurse should monitor for bradycardia. Diltiazem is a calcium channel blocker that works by slowing the heart rate and reducing blood pressure. Therefore, bradycardia, or a slow heart rate, can be an expected effect of this medication. Monitoring for bradycardia is important to ensure that the client is not experiencing a dangerously slow heart rate that could compromise perfusion. The other options can be ruled out based on the pharmacological actions of Diltiazem. Tachycardia (option A) is unlikely because Diltiazem works to slow the heart rate. Hypertension (option C) is also unlikely as Diltiazem is used to treat high blood pressure. Hyperkalemia (option D) is not a direct effect of Diltiazem, as it does not typically impact potassium levels in the body. Educationally, understanding the pharmacological effects of medications is crucial for nurses to provide safe and effective care to their patients. By knowing the expected outcomes and potential side effects of medications like Diltiazem, nurses can monitor for and address any complications that may arise, ensuring the best possible outcomes for their clients.
Question 5 of 5
A healthcare provider is caring for a client who is prescribed Digoxin. Which of the following laboratory values should the provider monitor to assess for potential toxicity?
Correct Answer: B
Rationale: In the context of pharmacology, it is crucial for healthcare providers to understand the specific monitoring requirements for medications to ensure patient safety and effective treatment. In the case of Digoxin, which is commonly prescribed for heart conditions, monitoring potassium levels is essential to assess for potential toxicity. Digoxin works by increasing intracellular calcium levels, and hypokalemia can potentiate its toxicity, leading to serious cardiac complications such as arrhythmias. Monitoring sodium levels (option A) is not directly related to Digoxin toxicity. While sodium imbalances can impact heart function, it is not the primary concern when monitoring for Digoxin toxicity. Similarly, monitoring magnesium levels (option C) is important for some medications but is not a primary concern for Digoxin toxicity. Magnesium imbalances can also affect cardiac function, but they are not the main focus when assessing Digoxin toxicity. Monitoring calcium levels (option D) is not typically required when assessing Digoxin toxicity. Calcium levels can influence cardiac contractility, but they are not directly linked to Digoxin toxicity as potassium levels are. Educationally, understanding the rationale behind monitoring potassium levels in Digoxin therapy highlights the interconnectedness of electrolytes and medications in pharmacology. It emphasizes the importance of comprehensive patient assessment and monitoring to prevent adverse drug reactions and ensure optimal therapeutic outcomes.